| NCT00527566 | Brigham and Women´s Hospital|GlaxoSmithKline | Churg Strauss Syndrome | 2007-09 | PHASE1|PHASE2 |
| NCT00086658 | GlaxoSmithKline | Hypereosinophilia|Hypereosinophilic Syndrome | 2004-03-23 | PHASE3 |
| NCT01520051 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|The Netherlands Asthma Foundation|GlaxoSmithKline | Asthma|Viral Infection | 2012-01 | PHASE3 |
| NCT06107101 | St. Paul´s Sinus Centre | Chronic Rhinosinusitis With Nasal Polyps | 2024-06-01 | PHASE4 |
| NCT05642806 | St. Paul´s Sinus Centre | Chronic Rhinosinusitis With Nasal Polyps|Asthma|Chronic Rhinosinusitis Without Nasal Polyps | 2023-07-01 | PHASE4 |
| NCT05147155 | University of Thessaly | Severe Asthma | 2021-04-19 | |
| NCT05689931 | Region Skane|Lund University | Asthma | 2023-02-01 | |
| NCT05320939 | Temple University|GlaxoSmithKline | COPD | 2023-04 | PHASE2 |
| NCT00274703 | GlaxoSmithKline | Oesophagitis, Eosinophilic | 2005-12 | PHASE2 |
| NCT04585997 | University of Newcastle, Australia|GlaxoSmithKline | Asthma|Eosinophilic Asthma | 2018-11-03 | PHASE4 |
| NCT05365841 | University of Crete | Severe Eosinophilic Asthma w+wo CRSwNP | 2022-05-15 | |
| NCT00097370 | GlaxoSmithKline | Hypereosinophilic Syndrome | 2004-09-30 | PHASE3 |
| NCT05063981 | Istituti Clinici Scientifici Maugeri SpA|University of Palermo|National Research Council | Severe Eosinophilic Asthma | 2021-11-25 | |
| NCT00802438 | University of Wisconsin, Madison | Asthma | 2008-06-01 | NA |
| NCT04133909 | GlaxoSmithKline|PPD Development, LP | Pulmonary Disease, Chronic Obstructive | 2019-10-30 | PHASE3 |
| NCT03453021 | University Hospital, Grenoble | Asthma; Eosinophilic | 2016-01-25 | |
| NCT01842607 | GlaxoSmithKline | Asthma | 2013-05-27 | PHASE3 |
| NCT03055195 | GlaxoSmithKline | Dermatitis, Atopic | 2017-03-21 | PHASE2 |
| NCT04965636 | GlaxoSmithKline | Hypereosinophilic Syndrome | 2022-07-14 | PHASE3 |
| NCT00358449 | GlaxoSmithKline | Oesophagitis, Eosinophilic | 2006-09-11 | PHASE2 |
| NCT04157348 | AstraZeneca | Eosinophilic Granulomatous Vasculitis | 2019-10-29 | PHASE3 |
| NCT05030155 | Assistance Publique - H?pitaux de Paris|French Vasculitis Study Group|URC-CIC Paris Descartes Necker Cochin | Eosinophilic Granulomatosis With Polyangiitis | 2022-05-30 | PHASE3 |
| NCT04075331 | University of Leicester|GlaxoSmithKline | COPD|Eosinophilia | 2020-09-07 | PHASE2|PHASE3 |
| NCT05938972 | University Hospital, Ghent | Chronic Rhinosinusitis With Nasal Polyps | 2022-03-01 | |
| NCT04641741 | Hospital Clinico Universitario de Santiago|GlaxoSmithKline | Asthma|Eosinophilic Asthma | 2021-04-01 | |
| NCT04276233 | GlaxoSmithKline|Tech Observer | Asthma | 2021-06-29 | PHASE4 |
| NCT05228041 | University Hospital, Lille | Chronic Rhinosinusitis With Nasal Polyps | 2022-02-10 | |
| NCT06041386 | GlaxoSmithKline | Asthma | 2024-03-20 | PHASE4 |
| NCT03476109 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain|University Hospital, Ghent|University of Liege|CHU de Charleroi|Erasme University Hospital|Centre Hospitalier Universitaire UCLouvain Namur|Universitair Ziekenhuis Brussel|Brugmann University Hospital|Grand H?pital de Charleroi|AZ Delta|Centre Hospitalier Universitaire Saint Pierre|KU Leuven | Severe Asthma | 2019-05-10 | PHASE4 |
| NCT04412044 | KU Leuven | Asthma | 2016-09-01 | PHASE4 |
| NCT06069310 | National and Kapodistrian University of Athens | Chronic Rhinosinusitis With Nasal Polyps|Severe Eosinophilic Asthma|Chronic Rhinosinusitis Without Nasal Polyps | 2023-09-01 | |
| NCT06298448 | University Medical Center Groningen|GlaxoSmithKline | EGPA - Eosinophilic Granulomatosis With Polyangiitis | 2024-02-14 | |
| NCT01691521 | GlaxoSmithKline | Asthma | 2012-10-08 | PHASE3 |
| NCT05441059 | Frisius Medisch Centrum|GlaxoSmithKline | Asthma Severe Persistent Uncontrolled | 2021-01-01 | |
| NCT00716651 | University Hospital Schleswig-Holstein|GlaxoSmithKline | Churg Strauss Syndrome | 2008-07 | PHASE2 |
| NCT03562195 | GlaxoSmithKline | Asthma | 2018-08-29 | PHASE3 |
| NCT03014674 | GlaxoSmithKline | Asthma | 2017-01-06 | PHASE3 |
| NCT03292588 | National Institute of Allergy and Infectious Diseases (NIAID)|Inner-City Asthma Consortium|GlaxoSmithKline|Rho Federal Systems Division, Inc. | Asthma | 2017-11-07 | PHASE2 |
| NCT04607005 | GlaxoSmithKline|BioClinica, Inc.|Signant Health | Nasal Polyps | 2021-04-22 | PHASE3 |
| NCT06258772 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Chronic Rhinosinusitis With Nasal Polyps | 2024-02-05 | |
| NCT05139381 | King´s College Hospital NHS Trust | Asthma in Children | 2022-03-02 | |
| NCT02555371 | GlaxoSmithKline | Asthma | 2016-01-07 | PHASE3 |
| NCT04914078 | Università degli Studi di Ferrara|GlaxoSmithKline | Severe Asthma | 2021-09-21 | |
| NCT02281318 | GlaxoSmithKline | Asthma | 2014-12-11 | PHASE3 |
| NCT06501807 | University Hospital, Lille | Rhinosinusitis Chronic|Nasal Polyps | 2024-09-02 | NA |
| NCT05263934 | GlaxoSmithKline | Eosinophilic Granulomatosis With Polyangiitis | 2022-07-14 | PHASE3 |
| NCT01366521 | GlaxoSmithKline | Asthma | 2011-02 | PHASE2 |
| NCT04183192 | Food and Drug Administration (FDA)|Spaulding Clinical Research LLC | Healthy Subjects|Pharmacokinetics|Pharmacodynamics | 2020-02-17 | PHASE1 |
| NCT01705795 | Insel Gruppe AG, University Hospital Bern | Pemphigoid, Bullous | 2013-02-13 | PHASE2 |
| NCT01000506 | GlaxoSmithKline | Asthma | 2009-11-01 | PHASE2 |
| NCT05902325 | Centre hospitalier de l´Université de Montréal (CHUM) | Chronic Rhinosinusitis With Nasal Polyps | 2023-10-03 | PHASE4 |
| NCT04924478 | University Hospital Southampton NHS Foundation Trust|GlaxoSmithKline | Asthma; Eosinophilic | 2021-07 | |
| NCT04305678 | Mayo Clinic|GlaxoSmithKline | Eosinophilic Fasciitis | 2023-02 | PHASE1 |
| NCT03739320 | Sotiria General Hospital | Severe Eosinophilic Asthma | 2017-12-11 | |
| NCT03099096 | GlaxoSmithKline | Asthma | 2017-05-04 | PHASE3 |
| NCT04512521 | Hannover Medical School|GlaxoSmithKline | Asthma; Eosinophilic | 2020-05-04 | |
| NCT01691859 | GlaxoSmithKline | Asthma | 2012-09-28 | PHASE3 |
| NCT06348173 | Université de Montréal|GlaxoSmithKline | Asthma | 2023-06-01 | |
| NCT02135692 | GlaxoSmithKline | Asthma | 2014-05-29 | PHASE3 |
| NCT02654145 | GlaxoSmithKline | Asthma | 2016-03-17 | PHASE4 |
| NCT02836496 | GlaxoSmithKline | Hypereosinophilic Syndrome | 2017-03-07 | PHASE3 |
| NCT07200336 | Eye & ENT Hospital of Fudan University | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | 2025-10-08 | PHASE4 |
| NCT00266565 | Children´s Hospital Medical Center, Cincinnati | Hypereosinophilic Syndromes|Eosinophilic Gastroenteritis|Churg-Strauss Syndrome|Eosinophilic Esophagitis | 2001-12 | PHASE1|PHASE2 |
| NCT03085797 | GlaxoSmithKline|CRF Health|Bristol-Myers Squibb | Nasal Polyps | 2017-05-25 | PHASE3 |
| NCT06572267 | Xijing Hospital | Coronary Artery Disease | 2024-10-16 | PHASE2 |
| NCT04128371 | National Institute of Allergy and Infectious Diseases (NIAID) | Eosinophilia|Angioedema | 2021-01-14 | PHASE2 |
| NCT06683261 | Universitaire Ziekenhuizen KU Leuven | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)|Chronic Rhinosinusitis (CRS) | 2022-09-23 | |
| NCT05923047 | Instituto de Investigación Marqués de Valdecilla | Rhinosinusitis Chronic|Polyp, Nasal | 2023-09-01 | PHASE4 |
| NCT05091385 | Medical University of Lodz|GlaxoSmithKline | Asthma; Eosinophilic | 2022-01-01 | |
| NCT05979051 | Guangdong Hengrui Pharmaceutical Co., Ltd | Eosinophilic Granulomatosis With Polyangiitis | 2023-11-16 | PHASE2|PHASE3 |
| NCT05895929 | Johns Hopkins University|GlaxoSmithKline | Chronic Rhinosinusitis With Nasal Polyps|Chronic Rhinosinusitis (Diagnosis) | 2023-09-05 | EARLY_PHASE1 |
| NCT05626777 | Hospices Civils de Lyon|GlaxoSmithKline | Asthma | 2023-03-09 | PHASE4 |
| NCT04578171 | Laval University|GlaxoSmithKline | Asthma | 2021-07-06 | |
| NCT05598814 | Vibeke Backer | Chronic Rhinosinusitis with Nasal Polyps|Asthma | 2023-04-01 | PHASE4 |
| NCT03021304 | GlaxoSmithKline | Asthma | 2017-02-01 | PHASE3 |
| NCT03298061 | GlaxoSmithKline | Churg-Strauss Syndrome|Eosinophilic Granulomatosis With Polyangiitis | 2015-04-14 | PHASE3 |
| NCT04612556 | Aristotle University Of Thessaloniki|NHS Pulmonary Clinic G. Papanikolaou Hospital, Thessaloniki, Greece|Pulmonary Clinic of Army Hospital Thessaloniki Greece|Pulmonary Clinic, Democritus University of Thrace|Pulmonary Clinic, University of Ioannina|1st Pulmonary Clinic, Kapodistrian University of Athens|2nd Pulmonary Clinic, Kapodistrian University of Athens|NHS 7th Pulmonary Clinic, Sotiria Hospital, Athens | Asthma; Eosinophilic|Severe Asthma|Late-Onset Asthma | 2021-01-22 | |
| NCT07343661 | Azienda Ospedaliero Universitaria di Cagliari | EGPA - Eosinophilic Granulomatosis With Polyangiitis|Severe Asthma|Eosinophilic Asthma | 2025-10-17 | PHASE4 |
| NCT04823585 | Helsinki University Central Hospital | Asthma, Aspirin-Induced|Chronic Rhinosinusitis With Nasal Polyps | 2021-08-12 | PHASE4 |
| NCT01691508 | GlaxoSmithKline | Asthma | 2012-10 | PHASE3 |
| NCT02377427 | GlaxoSmithKline | Asthma | 2015-08-25 | PHASE2 |
| NCT02020889 | GlaxoSmithKline|National Institute of Allergy and Infectious Diseases (NIAID) | Churg-Strauss Syndrome | 2014-02-05 | PHASE3 |
| NCT01463644 | McMaster University | Chronic Obstructive Pulmonary Diseases|Chronic Airways Limitation|Bronchitis | 2012-01 | PHASE3 |
| NCT03656380 | University of North Carolina, Chapel Hill|GlaxoSmithKline|University of Utah|Northwestern University|MNGI Digestive Health, P.A. | EoE|Eosinophilic Esophagitis | 2019-03-20 | PHASE2 |
| NCT04718389 | GlaxoSmithKline|IQVIA Pty Ltd | Asthma | 2021-01-26 | PHASE3 |
| NCT05576454 | Bio-Thera Solutions | Severe Asthma | 2022-09-20 | PHASE1 |
| NCT04550780 | University Hospital, Montpellier | Asthma | 2021-12-03 | |
| NCT04665141 | Clinica Universidad de Navarra, Universidad de Navarra|Hospital Clinic of Barcelona|Hospital Regional de Malaga | Asthma | 2021-04-07 | |
| NCT04765722 | McMaster University|University of Manchester | Chronic Cough|Eosinophilic Bronchitis|Asthma | 2021-12-14 | PHASE4 |
| NCT00244686 | GlaxoSmithKline | Hypereosinophilic Syndrome | | |
| NCT05942222 | Rigshospitalet, Denmark | Chronic Rhinosinusitis With Nasal Polyps|Asthma; Eosinophilic|Eosinophilia | 2023-04-27 | PHASE4 |
| NCT05189613 | Policlinico Universitario, Catania | Bronchial Asthma|Bronchiectasis | 2021-09-01 | NA |
| NCT02105948 | GlaxoSmithKline | Pulmonary Disease, Chronic Obstructive | 2014-04-15 | PHASE3 |
| NCT03306043 | GlaxoSmithKline | Hypereosinophilic Syndrome | 2017-11-13 | PHASE3 |
| NCT05138250 | Sheffield Teaching Hospitals NHS Foundation Trust|University of Sheffield | COPD | 2022-05-08 | PHASE3 |
| NCT02105961 | GlaxoSmithKline | Pulmonary Disease, Chronic Obstructive | 2014-04-24 | PHASE3 |
| NCT05708300 | Aristotle University Of Thessaloniki|Department of Otorhinolaryngology, Head and Neck Surgery, George Papanikolaou Hospital|Department of Otorhinolaryngology, Democritus University of Thrace, Alexandroupolis|Department of Pulmonology, Democritus University of Thrace, Alexandroupolis|Respiratory Medicine Department, University of Ioannina, Faculty of Medicine|Department of Respiratory Medicine, National and Kapodistrian University of Athens|Department of Allergy and Clinical Immunology, 424 General Military Training Hospital|Department of Otolaryngology, Head and Neck Surgery, Sotiria General Hospital|Pulmonary and Respiratory Failure Department, National and Kapodistrian University of Athens | Chronic Rhinosinusitis With Nasal Polyps|Asthma | 2024-02-23 | |
| NCT01362244 | GlaxoSmithKline | Nasal Polyps | 2009-05-12 | PHASE2 |
| NCT01471327 | GlaxoSmithKline | Asthma | 2011-08-09 | PHASE1 |